Hepatitis B virus reactivation during fludarabine therapy in non-Hodgkin's lymphoma

Leukemia and Lymphoma

Volumn 44, Issue 7, 2003, Pages 1249-1250

  Yavuz, Sinan ^a   Paydas, Semra ^a   Disel, Umut ^a   Sahin, Berksoy ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; LAMIVUDINE; PREDNISOLONE; VINCRISTINE;

ADULT; ARTICLE; CANCER GRADING; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FUNCTION TEST; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; VIRUS REACTIVATION;

ANTINEOPLASTIC AGENTS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; REMISSION INDUCTION; VIDARABINE; VIRUS ACTIVATION;

EID: 0038324195     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000079131     Document Type: Article

References (13)

1. Haskell, M.C. and Rosen, L. (2001) "Antineoplastic agents", In: Haskell, M.C. and Berek, J.S., eds, Cancer Treatment, 5th Ed., pp. 149-151.
2. Ng, H.J. and Lim, L.C. (2001) "Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report", Ann. Hematol. 80(9), 549-552.
3. Yeo, W., Chan, P.K., Zhong, S. et al. (2000) "Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors (abstract)", J. Med. Virol. 62(3), 299-307.
4. Xunrong, L., Yan, A.W., Liang, R. and Lau, G.K. (2001) "Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy - pathogenesis and management", Rev. Med. Virol. 11(5), 287-299.
5. Yeo, W., Steinberg, J.L., Tam, J.S. et al. (1999) "Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy", J. Med. Virol. 59(3), 263-269.
6. Yeo, W., Chan, P.K., Chan, H.L. et al. (2001) "Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replication precedes overt hepatitis", J. Med. Virol. 65(3), 473-477.
7. Liao, C.A., Lee, C.M., Wu, H.C. et al. (2002) "Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin's lymphoma", Br. J. Haematol. 116(1), 166-169.
8. Persico, M., De Marino, F., Russo, G.D. et al. (2002) "Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus-infected patients treated for non-Hodgkin lymphoma", Blood 99(2), 724-725.
9. Stroffolini, T., Andriani, A., Bibas, M. and Barlattani, A. (2002) "Successful treatment with lamivudine for reactivated hepatitis B infection following chemotherapy for non-Hodgkin's lymphoma", Ann. Hematol. 81(1), 48-49.
10. Endo, T., Sakai, T., Fujimoto, K. et al. (2001) "A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma", Bone Marrow Transplant. 27(4), 433-436.
11. Ahmed, A. and Keefee, E.B. (1999) "Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection", Am. J. Gastroenterol. 94(1), 249-251.
12. Al-Taie, O.H., Mork, H., Gassel, A.M. et al. (1999) "Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature", Ann. Hematol. 78(5), 247-249.
13. Ishiga, K., Kawatani, T., Suou, T. et al. (2001) "Fulminant hepatitis type B after chemotherapy in a serologically negative B virus carrier with acute myelogenous leukemia", Int. J. Hematol. 73(1), 115-118.